The largest database of trusted experimental protocols

Recombinant rat egf

Manufactured by Thermo Fisher Scientific
Sourced in United States

Recombinant rat EGF is a purified protein produced using recombinant DNA technology. It is a growth factor that stimulates cell proliferation and differentiation.

Automatically generated - may contain errors

2 protocols using recombinant rat egf

1

Growth Factor Supplementation in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
TGF-β2, EGF and FGF21 groups were supplemented with recombinant human TGF-β2 (97.3% homology with rat), recombinant rat EGF and recombinant human FGF21 (92% homology with rat) (all from Peprotech, Rocky Hill, NJ, USA). These products were reconstituted in phosphate-buffered solution (PBS, pH 7.2) with 0.1% bovine serum albumin (BSA, SeraCare Life Sciences, Milford, MA, USA), according to the manufacturer’s recommendations. The dose of TGF-β2 was 35 μg/kg/day, which was based on the amount of TGF-β2 found in mid-lactation rat milk and milk intake by pups at 4–14 days of age [13 (link)]. The dose of EGF was 100 μg/kg/day, which was demonstrated to be effective as a treatment in a rat model of NEC [29 (link)]. Finally, the dose of FGF21 was 5 μg/kg/day, an amount that was established in relation to TGF-β2, which was found in a 1:10 ratio FGF21:TGF-β2 [23 (link),30 (link)]. The REF group received a matched volume of the vehicle (1% BSA in PBS) used to dilute the GF.
+ Open protocol
+ Expand
2

Signaling Pathway Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant rat EGF was obtained from PeproTech (Cat. #400–25) and recombinant rat beta-NGF from R&D Systems (#556-NG-100). Recombinant human NRG1α (Cat. #296-HR) and NRG1β (Cat. #396-HB/CF) were obtained from R&D Systems. All ligands were reconstituted in sterile PBS containing 1 mg/ml bovine serum albumin (BSA) (Roche #03116956001). The following antibodies were used: phospho-p44/42 MAPK (ERK1/2) (pThr202/pTyr204) (E10) (Cell Signaling Technology (CST) #9106), p44/42 MAPK (ERK1/2) (L34F12) (CST #4696), Grb2 (C-23) (Santa Cruz #sc-255) and Grb2 (CST #3972), phospho-EGFR (pTyr1173) (53A5) (CST #4407), phospho-EGFR (pTyr845) (CST #2231), phospho-EGFR (pTyr1086) (CST #2220), phospho-EGFR (pTyr845) (CST #2234), hEGFR (Lab Vision Ab-15: ThermoFisher Sci MS-665-P0), EGFR (CST #2232), phospho-TrkA (pTyr674/675) (C50F3) (CST #4621), phospho-TrkA (pTyr490) (CST #9141), phospho-TrkA (pTyr785) (C67C8) (CST #4168), phospho-TrkA (pTyr785) (R&D #AF5479), TrkA (R&D #AF1056), Rap1A/Rap1B (26B4) (CST #2399), FRS2 (Fisher Sci #PA124685), phospho-ErbB4 (pTyr1242) (4C6) (Santa Cruz #sc81491), phospho-ErbB4 (pTyr1284) (21A9) (CST #4757) and anti-FLAG (CST #2044). The following kinase inhibitors were used: Gö7874 (Calbiochem #365252), erlotinib (CST #5083), and the dynamin GTPase inhibitor Dyngo 4a (Abcam #ab120689).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!